Immune cells at the maternal-fetal interface lack punchthey are weak and disarmed, shielding the fetus from attack by the mother. But how do such cells also manage to attack infectious agents like viruses? A new study of human tissue suggests that immune cells at the maternal-fetal interface can shuttle between a non-activated and an activated state in response to viral infection [1] .
In early pregnancy, the maternal-fetal interface is populated by decidual NK (dNK) cells. These NK cells are in a tolerogenic, low-activity state, which is thought to be induced in part via HLA-G, a molecule expressed almost exclusively in fetal extravillous trophoblasts (EVTs)-cells that invade maternal decidual tissue during pregnancy.
Tamara Tilburgs and J. Henry Evans et al. examined cocultures of primary EVT and dNK with high-resolution confocal microscopy. They report that filopodia from EVT make contacts with dNK cells (Fig. 1) . They also provide evidence that the EVT transfer HLA-G to dNK cells via a form of direct transfer, trogocytosis (from the ancient Greek trogo, meaning 'gnaw').
The researchers then activated the dNK cells in culture with IL-15, which is known to ramp up dNK cell-killing activity. They found that culture with IL-15 resulted in the disappearance of HLA-G from dNK cells. The researchers also exposed dNK cells to cells infected with HCMV (human cytomegalo virus), a common infection during pregnancy-and found an increase in cytotoxicity, an effect amplified by IL-15. Finally, they showed that dNK cells exposed to IL-15 could re-acquire HLA-G upon culture with EVT.
The findings suggest that dNK cells can switch between tolerance and antiviral immunity through the acquisition and disappearance of HLA-G.
